PL1651596T3 - Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje - Google Patents
Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycjeInfo
- Publication number
- PL1651596T3 PL1651596T3 PL04786279T PL04786279T PL1651596T3 PL 1651596 T3 PL1651596 T3 PL 1651596T3 PL 04786279 T PL04786279 T PL 04786279T PL 04786279 T PL04786279 T PL 04786279T PL 1651596 T3 PL1651596 T3 PL 1651596T3
- Authority
- PL
- Poland
- Prior art keywords
- aminobutane
- dithiobis
- sulfonates
- compositions
- same
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 208000037849 arterial hypertension Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0309700A FR2858617A1 (fr) | 2003-08-06 | 2003-08-06 | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
EP04786279A EP1651596B1 (fr) | 2003-08-06 | 2004-08-06 | Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant |
PCT/FR2004/002106 WO2005014535A1 (fr) | 2003-08-06 | 2004-08-06 | Derives de 4,4’-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1651596T3 true PL1651596T3 (pl) | 2010-08-31 |
Family
ID=34073059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04786279T PL1651596T3 (pl) | 2003-08-06 | 2004-08-06 | Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje |
Country Status (14)
Country | Link |
---|---|
US (1) | US7582797B2 (pl) |
EP (1) | EP1651596B1 (pl) |
JP (1) | JP4718461B2 (pl) |
AT (1) | ATE455097T1 (pl) |
CA (1) | CA2533432C (pl) |
CY (1) | CY1109950T1 (pl) |
DE (1) | DE602004025119D1 (pl) |
DK (1) | DK1651596T3 (pl) |
ES (1) | ES2339354T3 (pl) |
FR (1) | FR2858617A1 (pl) |
PL (1) | PL1651596T3 (pl) |
PT (1) | PT1651596E (pl) |
SI (1) | SI1651596T1 (pl) |
WO (1) | WO2005014535A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
CN102171185A (zh) | 2008-08-01 | 2011-08-31 | 拜奥西尼斯医药股份有限公司 | 甲硫氨酸类似物及其使用方法 |
EP2439192A1 (en) * | 2010-10-07 | 2012-04-11 | Quantum Genomics | Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) |
EA028718B1 (ru) * | 2011-12-21 | 2017-12-29 | Квантум Дженомикс | Способ лечения артериальной гипертензии или косвенно или прямо связанных заболеваний |
EP2722327A1 (en) * | 2012-10-22 | 2014-04-23 | Quantum Genomics | Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine |
EP3207036A4 (en) * | 2014-10-17 | 2018-08-15 | University of Florida Research Foundation | Novel small molecule anticancer agents |
TW202100146A (zh) | 2019-03-11 | 2021-01-01 | 法商量子基因科技有限公司 | 用於治療高血壓或心衰竭的化合物及包含其之組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5021134A1 (es) * | 1998-05-01 | 2001-03-27 | Abbott Lab | Inhibidores beta-aminoacidos substituidos de aminopeptida- sa-2 metionina |
US6919307B2 (en) * | 2000-11-01 | 2005-07-19 | Praecis Pharmaceuticals, Inc. | Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
EP1381360A4 (en) * | 2001-03-29 | 2009-12-02 | Smithkline Beecham Corp | COMPOUNDS AND METHODS FOR INHIBITING METAP2 IN MAMMALS |
-
2003
- 2003-08-06 FR FR0309700A patent/FR2858617A1/fr not_active Withdrawn
-
2004
- 2004-08-06 US US10/567,362 patent/US7582797B2/en active Active
- 2004-08-06 PT PT04786279T patent/PT1651596E/pt unknown
- 2004-08-06 DK DK04786279.2T patent/DK1651596T3/da active
- 2004-08-06 PL PL04786279T patent/PL1651596T3/pl unknown
- 2004-08-06 ES ES04786279T patent/ES2339354T3/es active Active
- 2004-08-06 WO PCT/FR2004/002106 patent/WO2005014535A1/fr active Application Filing
- 2004-08-06 EP EP04786279A patent/EP1651596B1/fr active Active
- 2004-08-06 SI SI200431385T patent/SI1651596T1/sl unknown
- 2004-08-06 CA CA2533432A patent/CA2533432C/fr not_active Expired - Fee Related
- 2004-08-06 AT AT04786279T patent/ATE455097T1/de active
- 2004-08-06 JP JP2006522380A patent/JP4718461B2/ja not_active Expired - Fee Related
- 2004-08-06 DE DE602004025119T patent/DE602004025119D1/de active Active
-
2010
- 2010-03-23 CY CY20101100285T patent/CY1109950T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
FR2858617A1 (fr) | 2005-02-11 |
CY1109950T1 (el) | 2014-09-10 |
JP2007501204A (ja) | 2007-01-25 |
SI1651596T1 (sl) | 2010-06-30 |
DK1651596T3 (da) | 2010-05-10 |
DE602004025119D1 (de) | 2010-03-04 |
EP1651596B1 (fr) | 2010-01-13 |
US7582797B2 (en) | 2009-09-01 |
ES2339354T3 (es) | 2010-05-19 |
WO2005014535A1 (fr) | 2005-02-17 |
EP1651596A1 (fr) | 2006-05-03 |
CA2533432A1 (fr) | 2005-02-17 |
PT1651596E (pt) | 2010-04-16 |
JP4718461B2 (ja) | 2011-07-06 |
ATE455097T1 (de) | 2010-01-15 |
CA2533432C (fr) | 2013-05-21 |
US20060205695A1 (en) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2017C018I2 (pl) | ||
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
MXPA03010207A (es) | Nuevas 4-anilinoquinolin-3-carboxamidas. | |
WO2003006425A3 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
YU84603A (sh) | Novi inhibitori tirozin kinaze | |
TNSN07235A1 (en) | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride | |
WO2004004657A3 (en) | Hiv integrase inhibitors | |
MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
CY1109950T1 (el) | Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν | |
ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
HRP20050082A2 (en) | 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors | |
MXPA04002282A (es) | Nuevos compuestos y preparaciones como inhibidores de la catepsina. | |
MXPA03010766A (es) | Nuevos compuestos y composiciones como inhibicores de las catepsinas. | |
MXPA04003755A (es) | Endoprotesis vasculares. | |
MY140081A (en) | Pharmaceutical formulations of modafinil | |
GB0229081D0 (en) | Multifunctional cationic photoinitiators, their preparation and use | |
MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
MXPA04003910A (es) | Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar. | |
MXPA04005151A (es) | Compuestos terapeuticos. | |
YU34604A (sh) | Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže | |
TW200503672A (en) | 2-aminobenzoyl derivatives | |
GB0309440D0 (en) | Quinolone derivatives | |
RS20050421A (en) | Aminoindazole derivatives and use thereof as kinase inhibitors |